PRESIDENT AND CFO · Alto Neuroscience, Inc. · Alto Neuroscience, Inc. — Employee Stock Option (Right to Buy)
Side
M
Value
—
Shares
55.0K
Price
—
Executed
Oct 2, 2026
Disclosed
Oct 5, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Oct 2 executedOct 5, 2026 disclosed
ANRO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 2286.9% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Alto Neuroscience, Inc. — Employee Stock Option (Right to Buy)
Ticker
ANRO
Shares
55.0K
Price per share
$0
Execution date (reported)
Oct 2, 2026
Owned after transaction
57.4K shares
Days from execution to publication
3
What this establishes
Smith Nicholas Conrad filed this Form 4 reporting a option exercise of ANRO on Oct 2, 2026. It became public on Oct 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
PRESIDENT AND CFO
Smith Nicholas Conradcik:0002009130
Issuer
Alto Neuroscience, Inc.cik:0001999480
Revision history · 0
No field has changed since this record was first ingested.
